US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Ipsogen SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Ipsogen SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Novartis Vaccines and Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Novartis Vaccines and Diagnostics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership ...  |  read more...
USD 350
Senesco Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Senesco Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
RTI Biologics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' RTI Biologics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Agenus, Inc. (formerly Antigenics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Agenus, Inc. (formerly Antigenics, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership ...  |  read more...
USD 350
Rosetta Genomics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Rosetta Genomics, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Transgene SA - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Transgene SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Analysis of the US LIMS Market
11/21/2014 | published by: Frost & Sullivan
... Web sites and credible sources Public announcements and plans by key market leaders, suppliers, and new entrants Frost & Sullivan’s published research and market and technology expertise All market figures and shares listed in the ...  |  read more...
USD 6,000
Silent Information Regulator 2 Protein (Sir2 Protein or Sirtuin) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Silent Information Regulator 2 Protein (Sir2 Protein or Sirtuin) Inhibitors. This ...  |  read more...
USD 1,250
Baking Ingredients Market by Type (Enzymes, Emulsifiers, Leavening agents, Fats & Shortenings, Mold Inhibitors, Colors & Flavors), Application (Bread, Biscuits & Cookies, Cakes & Pastries, Rolls & Pies) & Region - Global Trends & Forecast to 2019
11/24/2014 | published by: MarketsandMarkets
... Forecast to 2019 Baking ingredients are widely used in baking applications such as bread, biscuits & cookies, cakes & pastries, rolls & pies, pizzas, donuts, and frozen baked products. These ingredients are used to enhance ...  |  read more...
USD 4,650
China Recombinant Protein Drug Industry Report, 2014-2017
11/19/2014 | published by: Research in China
... protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%, and it is projected that China will see its actual demand for recombinant protein drugs exceed RMB40 billion in 2014. The start ...  |  read more...
USD 2,500
Conference Documentation: Advances in Cell Based Assays
11/11/2014 | published by: SMI Publishing, Ltd
... and strategies to accelerate go/no-go decision making in early and clinical development. Key academic, government and industry figures cover topics encompassing: Case studies in idiopathic pulmonary fibrosis (IPF) and molecular characterisation of solid tumors Interactive ...  |  read more...
USD 788.78
Global Bone Cements Industry 2014 Market Research Report
11/20/2014 | published by: 9Dimen Research
... the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Bone Cements basic information including Bone Cements definition, classification, ...  |  read more...
USD 2,850
ICON plc (ICLR) - Financial and Strategic SWOT Analysis Review
11/25/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 300
Celgene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Celgene Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Anti-CD19 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD19 Antibody. This report provides information on the therapeutic development based on the Anti-CD19 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD28 Antibody. This report provides information on the therapeutic development based on the Anti-CD28 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD30 Antibody. This report provides information on the therapeutic development based on the Anti-CD30 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD33 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD33 Antibody. This report provides information on the therapeutic development based on the Anti-CD33 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD37 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD37 Antibody. This report provides information on the therapeutic development based on the Anti-CD37 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD70 Antibody. This report provides information on the therapeutic development based on the Anti-CD70 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... to establish the understanding for all the pipeline drugs that fall under Aurora A Kinase Inhibitors. This report provides information on the therapeutic development based on the Aurora A Kinase Inhibitors dealing with mechanism of ...  |  read more...
USD 1,250
Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
11/24/2014 | published by: MarketLine
... Project Description: MarketLines' Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture ...  |  read more...
USD 350
Metabolomics: Technologies and Applications - A Global Market Overview
11/26/2014 | published by: Industry Experts
... the lingering uncertainties as to the advantages offered by metabolomics that have been the outcome of failed proteomics and genomics research programs. Through some recent accomplishments have been able to dispel some of these doubts, ...  |  read more...
USD 4,410
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Activation Protein (FAP or Seprase) Inhibitors. This report provides information on the therapeutic development based on ...  |  read more...
USD 1,250
1  2    4    6  7  8  9  10